New Frontiers inSchistosomaGenomics and Transcriptomics

New Frontiers in Schistosoma Genomics and Transcriptomics

Schistosomes are digenean blood flukes of aves and mammals comprising 23 species. Some species are causative agents of human schistosomiasis, the second major neglected disease affecting over 230 million people worldwide. Modern technologies including the sequencing and characterization of nucleic acids and proteins have allowed large-scale analyses of parasites and hosts, opening new frontiers...

NEW FRONTIERS IN ANGIOGENESIS New Frontiers in Angiogenesis

Genomic medicine: new frontiers and new challenges.

BACKGROUND The practice of personalized medicine has made large strides since the introduction of high-throughput technologies and the vast improvements in computational biotechnology. The personalized-medicine approach to cancer management holds promise for earlier disease detection, accurate prediction of prognosis, and better treatment options; however, the early experience with personalized...

Infantile hemangiomas: new frontiers.

Guest Editorial I t is a very exciting time for clini-cians who are confronted with infantile hemangiomas. So much new information is now available regarding pathogenesis, epidemiology, differential diagnosis, and therapy. These aspects are reviewed in greater detail in the accompanying articles by a group of experienced scientists and clinicians, who help provide a richer and more sophisticate...

New frontiers in arrhythmias.

Understanding of the mechanisms responsible for disorders of cardiac rhythm has been increasing rapidly in the past I0 years. A great stimulus to these advances in knowledge has been the recognition in Coronary Care Units of the high mortality associated with some arrhythmias. The principal inroads that have been made into the high mortality of patients with acute myocardial infarction who are ...